Evidence map›Paper›PMID 26106156›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Engineered cellular gene-replacement platform for selective and inducible proteolytic profiling.

Charles W Morgan, Juan E Diaz, Samantha G Zeitlin, Daniel C Gray, James A Wells

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Caspases and their substrates.Cell death and differentiation · 2017
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Charles W MorganChemistry and Chemical Biology Graduate Program, University of California, San Francisco, CA 94143; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94143.
Juan E DiazDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143;
Samantha G ZeitlinDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143;
Daniel C GrayChemistry and Chemical Biology Graduate Program, University of California, San Francisco, CA 94143; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94143.
James A WellsDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94143 jim.wells@ucsf.edu.
University of California, San Francisco · US

Funding

RESEARCH TRAINING IN CHEMISTRY AND CHEMICAL BIOLOGYT32GM064337 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIK, CHARLES SCOTT · 2002 to 2021
$7.8M
Global Analysis of Proteolysis in ApoptosisR01GM081051 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WELLS, JAMES A · 2007 to 2015
$2.8M
Direct Chemical Activators of CaspasesR01CA136779 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WELLS, JAMES A · 2009 to 2013
$1.5M
Regulating Proteolysis to Dissect ApoptosisR01GM097316 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WELLS, JAMES A · 2011 to 2014
$1.1M
NCI NIH HHS R01 CA136779NCI NIH HHS R01CA136779NIGMS NIH HHS 1R01GM097316-01NIGMS NIH HHS 5R01GM081051-08NIGMS NIH HHS R01 GM081051NIGMS NIH HHS R01 GM097316NIGMS NIH HHS T32 GM064337
6 · The paper itself

Abstract

Cellular demolition during apoptosis is completed by executioner caspases, that selectively cleave more than 1,500 proteins but whose individual roles are challenging to assess. Here, we used an optimized site-specific and inducible protease to examine the role of a classic apoptotic node, the caspase-activated DNase (CAD). CAD is activated when caspases cleave its endogenous inhibitor ICAD, resulting in the characteristic DNA laddering of apoptosis. We describe a posttranscriptional gene replacement (PTGR) approach where endogenous biallelic ICAD is knocked down and simultaneously replaced with an engineered allele that is susceptible to inducible cleavage by tobacco etch virus protease. Remarkably, selective activation of CAD alone does not induce cell death, although hallmarks of DNA damage are detected in human cancer cell lines. Our data strongly support that the highly cooperative action of CAD and inhibition of DNA repair systems are critical for the DNA laddering phenotype in apoptosis. Furthermore, the PTGR approach provides a general means for replacing wild-type protein function with a precisely engineered mutant at the transcriptional level that should be useful for cell engineering studies.

Indexed as

ApoptosisApoptosis Regulatory ProteinsCaspasesCell CycleCell SurvivalDeoxyribonucleasesFlow CytometryGene Knockdown TechniquesHEK293 CellsHeLa CellsHumansImmunoblottingMutationProteolysisReverse Transcriptase Polymerase Chain ReactionTransfectionApoptosis Regulatory Proteinscaspase-activated deoxyribonucleasecaspase-activated DNase inhibitorCaspasesDeoxyribonucleasesapoptosisDNA damageICADsite-specific proteolysisTEV protease

Identifiers

PMID26106156
PMCPMC4500269
OpenAlexW1526125918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.